Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 18, Issue 2, 2003, Pages 370-377

  Chuang, Chiao Lin ^b   Liu, Ren Shyan ^b   Wei, Yau Huei ^a   Huang, Tung Po ^a,b   Tarng, Der Cherng ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Functional iron deficiency; Haemodialysis; High fluorescence reticulocyte; Intravenous iron therapy; Recombinant human erythropoietin; Reticulocyte haemoglobin content

Indexed keywords

FERRITIN; IRON; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ANAPHYLAXIS; ARTICLE; CARDIOVASCULAR SYMPTOM; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG RESPONSE; DRUG WITHDRAWAL; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; FLUORESCENCE ANALYSIS; HEMATOCRIT; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HEMOSIDEROSIS; HUMAN; INFECTION; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON OVERLOAD; IRON THERAPY; LIVER DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RELIABILITY; RETICULOCYTE COUNT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TRANSFERRIN BLOOD LEVEL;

ANEMIA, IRON-DEFICIENCY; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRIC COMPOUNDS; FLUORESCENCE; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RETICULOCYTE COUNT; RETICULOCYTES;

EID: 0037312617     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.2.370     Document Type: Article

References (23)

1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of phase I and II clinical trial. N Engl J Med 1987; 316: 73-78
2. Besarab A, Amin N, Ahsan M et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000; 11: 530-538
3. Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J. A randomized trial of iron deficiency testing strategies in hemodialysis patients. Kidney Int 2001; 60: 2406-2411
4. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 [Suppl 3]: S192-S240
5. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Target guideline 6: assessing and optimizing iron stores. Nephrol Dial Transplant 1999; 14 [Suppl 5]: 14-15
6. Burns DL, Pomposelli JJ. Toxicity of parenteral iron dextran therapy. Kidney Int 1999; 55 [Suppl 69]: S119-S124
7. Kletzmayr J, Sunder-Plassmann G, Hörl WH. High dose intravenous iron: a note of caution. Nephrol Dial Transplant 2002; 17: 962-965
8. Fishbane S, Imbriano LJ, Kowalski EA, Maesaka JK. The evaluation of iron status in patients receiving recombinant human erythropoietin. J Am Soc Nephrol 1996; 7: 2654-2657
9. Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int 2000; 55 [Suppl 69]: S107-S118
10. Stenvinkel P, Heimburger O, Tuck CH, Berglund L. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 1998; 53: 1336-1342
11. Macdougall IC, Cavill I, Hulme B et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992; 304: 225-226
12. Bovy C, Tsobo C, Crapanzano L et al. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney Int 1999; 56: 1113-1119
13. Hörl WH. Measurement of hypochromic red blood cells is not the first line procedure to identify the patient with iron deficiency. Nephrol Dial Transplant 1998; 13: 850-851
14. Davis BH, Bigeloe NC. Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index. Arch Pathol Lab Med 1989; 113: 684-689
15. Fishbane S, Galgano C, Langley RC, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-222
16. Mittman N, Sreedhara R, Mushnick R et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEpo. Am J Kidney Dis 1997; 30: 912-922
17. Chang CC, Kass L. Clinical significance of immature reticulocyte fraction determined by automated reticulocyte counting. Am J Clin Pathol 1997; 108: 69-73
18. Tatsumi N, Izumi T. Reticulocyte maturation index as a useful diagnostic parameter. Sysmes Int 1991; 1: 23-28
19. Davis BH, Bigelow NC, Ball ED et al. Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation. Am J Hematol 1989; 32: 81-87
20. Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995; 26: 41-46
21. Macdougall IC, Tucker B, Thompson J, Tomsen CR, Baker LRI, Raine AEG. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50: 1694-1699
22. Brugnara C, Collella GM, Cremins J et al. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron deficient erythropoiesis. J Lab Clin Med 1994; 123: 660-667
23. Major A, Bauer C, Breumann C et al. rH-erythropoietin stimulates immature reticulocyte release in man. Br J Haematol 1996; 81: 434-441